CerTest CLIA SARS-CoV-2 Plate is an antigen detection product.

Quantitative detection of SARS-CoV-2 antigen in human nasopharyngeal swabs specimens is possible with our plates.

CLIA technique is more sensitive that other immunological techniques, which is a great advantage in the rapid and accurate diagnosis of infectious diseases.

Clinically, patients with SARS-CoV-2 infection tend to suffer symptoms such as olfactory and gustatory dysfunction, fever, dry cough, ansomia, fatigue, dyspnoea, headache, diarrhoea and sore throat, followed by vascular and systematic complications. COVID-19 commonly results in pneumoia, which can evolve into acute respiratory distress syndrome, leading to respiratory or multiorgan failure.

On March 11, 2020, the WHO declared the disease a pandemic, due to the high number of infected people and the rapidity of tis spread worldwide.

CerTest CLIA SARS-CoV-2 plates are:

• Accurate. CerTest CLIA technology is high accurate.
• Adaptable to any CLIA plate analyzer.
• Saving time and low manipulation. Plate, reagent, and samples are placed directly on the analyzer. No manipulation from technician is needed.
• Easy interpretation. Positive or negative result will be programmed. Total RLUs will also be shown, so quantitative interpretation is possible.